🇺🇸 FDA
Company

CAPRICOR

CAPRICOR THERAPEUTICS, INC.

CAPR pharma USA

Quick answer

CAPRICOR is a pharma company (CAPR) headquartered in SAN DIEGO, CA, USA with 8 tracked pipeline programs.

Pipeline (8)

project

Deramiocel (CAP-1002)

Muscular Dystrophies

Phase 3 · mab · active

1 trials project

Allogeneic Cardiosphere-Derived Cells (CAP-1002)

Duchenne Muscular Dystrophy

Phase 2 · small_molecule · completed

2 trials project

CAP-1002

Covid19

Phase 2 · mab · completed

1 trials project

CAP-1002

Muscular Dystrophies

Phase 2 · mab · completed

1 trials project

CAP-1002 Allogeneic Cardiosphere-Derived Cells

Myocardial Infarction

Phase 2 · mab · terminated

1 trials project

Cenderitide

Heart Failure

Phase 2 · small_molecule · completed

2 trials project

Deramiocel (CAP-1002)

Duchenne Muscular Dystrophy

Phase 2 · mab · active

1 trials project

Allogeneic Cardiosphere-Derived Cells (CDCs)

Dilated Cardiomyopathy (DCM)

Phase 1 · mab · active

1 trials

Patents (8)

patent

US 11801268

Methods of treating ocular inflammation and chemical injuries of the eye with ex

Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11759482

Methods and compositions for treating skeletal muscular dystrophy

Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10695293

Method of preventing or treating radiation-induced dermatitis with extracellular

Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10369173

Optimized methods for generation of cardiac stem cells from cardiac tissue and t

Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9884076

Optimized methods for generation of cardiac stem cells from cardiac tissue and t

Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9623085

Chimeric natriuretic peptide compositions and methods of preparation

Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9616107

Therapy for kidney disease and/or heart failure

Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9314507

Methods of treatment of heart failure with natriuretic peptides

Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)